The Group's first project, GT0918 (Proxalutamide tablets), has been awarded as the National Special Project for "Significant Novel Drugs Development" during the 12th Five-Year Plan period

(Summary description)

The Group's first project, GT0918 (Proxalutamide tablets), has been awarded as the National Special Project for "Significant Novel Drugs Development" during the 12th Five-Year Plan period

(Summary description)

Information
The Group's first project, GT0918 (Proxalutamide tablets), has been awarded as the National Special Project for "Significant Novel Drugs Development" during the 12th Five-Year Plan period

Scan the QR code to read on your phone